Amgen Urges Adoption Of Balanced Policies For Biosimilars

Chad Pettit Discusses Amgen’s Unique Perspective On Biosimilars

 
• By Dave Wallace
  
Rocks stacked
Balance is key when talking about biosimilar policies • Source: Shutterstock

More from Market Intelligence

More from In Vivo